Global Injection Pen Market Insights, Size and Growth Forecast To 2027

Global Injection Pen Market- By Type (Disposable and Reusable Pens), By Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.

Global Injection Pen Market- By Type (Disposable and Reusable Pens), By Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.

Published: Oct 2020 Report ID: HLCA2041 Pages: 1 - 250 Formats*:     
Category : Healthcare
The Global Injection pens market will emerge the market share owing diabetic population and convenient product. The Global injection pens market will anticipate the CAGR in the forecast period from 2020-2027. The application prospects of injection pens are rising owing to the emerging older population, a growing number of diabetic patients, increasing chronic diseases such as rheumatoid arthritis, fertility, osteoporosis treatment, and others have fueled the market of injection pens.
The injections pens have helped in overcoming some problems, like the amount of insulin and improper difficulties faced by elderly patients. Disposable and reusable injection pens are improving the quality of the life of diabetic patients. Therefore, these factors are attributing to the growing demand for diabetes injection pens during the forecast period. 
Moreover, injections pens are very convenient for a diabetic patient to use and carry and avoids the risk of accidentally breaking the syringe while using a glass syringe to inject insulin. Thus, this product has warmly adopted by the diabetic patient and contributing to fueling the demand for the market sales of the injection pens.

Type Overview in the Global Injection Pens Market
Based on the Type, the global Injection Pen market bifurcated into Disposable and Reusable Pens. The disposable injection pens segment will hold a significant share in the worldwide injection pens market. The disposable injection pens are widely adopted and used by diabetic patients owing to the less risk of spreading infection. Also, it is very convenient as it is flexible for the patient to carry, coupled with cost-effectiveness and advantage of precise dosage in the injection has helped in making patient independent on others.

Therapy Overview in the Global Injection Pens Market
Based on the therapy, the global Injection Pen market classified into Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility. The diabetes segment has dominated the demand for the worldwide injection pens market. The diabetics patients require to inject insulin in their skin tissues as their natural insulin mostly damaged in the body. Thus, earlier syringes and other methods were painful, and the high risk of infection and no dosage adjustment feature was present in them. Therefore, with injections, pens are more compatible, flexible, and cost-effective like elements have helped in dominating the diabetic market.

End-uses Overview in the Global Injection Pens Market
Based on the End-uses, the global Injection Pen market aggregated into Homecare and Hospitals. The home care segment will dominate the market share of the worldwide injection pens market. The injection pen market has bolstered its demand owing to its portability and flexibility, which helps the diabetic patient to use it by themselves without the doctor's presence. Therefore, the global injection pens market is emerging due to the significant usage in the homecare.

Region Overview in the Global Injection Pens Market
Based on geography, the global Injection Pen market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region is the fastest-growing region for injection pens, mainly due to the region's rapid economic growth and technology up-gradation in healthcare facilities. Also, the rise in the prevalence of diabetic patients and other chronic diseases that needed injection pens for the treatment is driving the market demand for the global injection pens market.

Global Injection Pens Market: Competitive Landscape
Companies such as Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd among others are key players in the global Injection Pen market.




1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation

2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition 
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation 

3. Executive Summary

4. Market Insights
4.1. Economic Factor Analysis 
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Competitors & Product Analysis
4.3. Regulatory Framework
4.4. Company market share analysis, 2019
4.5. Porter’s Five forces analysis
4.6. New Investment Analysis
4.7. PESTEL Analysis

5. Global Injection Pen Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Type 
5.2.1.1. Disposable injection pens
5.2.1.2. Reusable injection pen
5.2.2. By Therapy
5.2.2.1. Diabetes
5.2.2.1.1. Insulin
5.2.2.1.2. GLP-1
5.2.2.2. Growth hormone therapy
5.2.2.3. Fertility
5.2.2.4. Osteoporosis
5.2.2.5. Other therapies
5.2.3. By End-use
5.2.3.1. Hospitals
5.2.3.2. Home care
5.2.4. By Region
5.2.4.1. Europe
5.2.4.2. North America
5.2.4.3. Asia Pacific
5.2.4.4. South America 
5.2.4.5. Middle East & Africa 

6. Europe Injection Pen Market Overview
6.1. Europe Injection Pen Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. Europe Injection Pen Market Share & Forecast, 2016-2027
6.2.1. By Type 
6.2.1.1. Disposable injection pens
6.2.1.2. Reusable injection pen
6.2.2. By Therapy
6.2.2.1. Diabetes
6.2.2.1.1. Insulin
6.2.2.1.2. GLP-1
6.2.2.2. Growth hormone therapy
6.2.2.3. Fertility
6.2.2.4. Osteoporosis
6.2.2.5. Other therapies
6.2.3. By End-use
6.2.3.1. Hospitals
6.2.3.2. Home care
6.2.4. By Country
6.2.4.1. Germany
6.2.4.2. UK
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Rest of Europe
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on Europe Injection Pen Market 

7. North America Injection Pen Market Overview
7.1. North America Injection Pen Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. North America Injection Pen Market Share & Forecast, 2016-2027
7.2.1. By Type 
7.2.1.1. Disposable injection pens
7.2.1.2. Reusable injection pen
7.2.2. By Therapy
7.2.2.1. Diabetes
7.2.2.1.1. Insulin
7.2.2.1.2. GLP-1
7.2.2.2. Growth hormone therapy
7.2.2.3. Fertility
7.2.2.4. Osteoporosis
7.2.2.5. Other therapies
7.2.3. By End-use
7.2.3.1. Hospitals
7.2.3.2. Home care
7.2.4. By Country
7.2.4.1. US
7.2.4.2. Canada
7.2.4.3. Mexico
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on North America Injection Pen Market 

8. Asia Pacific Injection Pen Overview
8.1. Asia Pacific Injection Pen Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Injection Pen Market Share & Forecast, 2016-2027
8.2.1. By Type 
8.2.1.1. Disposable injection pens
8.2.1.2. Reusable injection pen
8.2.2. By Therapy
8.2.2.1. Diabetes
8.2.2.1.1. Insulin
8.2.2.1.2. GLP-1
8.2.2.2. Growth hormone therapy
8.2.2.3. Fertility
8.2.2.4. Osteoporosis
8.2.2.5. Other therapies
8.2.3. By End-use
8.2.3.1. Hospitals
8.2.3.2. Home care
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Injection Pen Market 

9. South America Injection Pen Market Overview
9.1. South America Injection Pen Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Injection Pen Market Share & Forecast, 2016-2027
9.2.1. By Type 
9.2.1.1. Disposable injection pens
9.2.1.2. Reusable injection pen
9.2.2. By Therapy
9.2.2.1. Diabetes
9.2.2.1.1. Insulin
9.2.2.1.2. GLP-1
9.2.2.2. Growth hormone therapy
9.2.2.3. Fertility
9.2.2.4. Osteoporosis
9.2.2.5. Other therapies
9.2.3. By End-use
9.2.3.1. Hospitals
9.2.3.2. Home care
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Injection Pen Market

10. Middle East & Africa Injection Pen Market Overview
10.1. Middle East & Africa Injection Pen Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Injection Pen Market Share & Forecast, 2016-2027
10.2.1. By Type 
10.2.1.1. Disposable injection pens
10.2.1.2. Reusable injection pen
10.2.2. By Therapy
10.2.2.1. Diabetes
10.2.2.1.1. Insulin
10.2.2.1.2. GLP-1
10.2.2.2. Growth hormone therapy
10.2.2.3. Fertility
10.2.2.4. Osteoporosis
10.2.2.5. Other therapies
10.2.3. By End-use
10.2.3.1. Hospitals
10.2.3.2. Home care
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Injection Pen Market

11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel 
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Novo Nordisk
11.7.2. Eli Lilly
11.7.3. Sanofi 
11.7.4. Merck 
11.7.5. Ypsomed 
11.7.6. AstraZeneca 
11.7.7. F.Hoffman-La Roche 
11.7.8. Becton Dickinson and Company 
11.7.9. Owen Mumford 
11.7.10. Novartis 
11.7.11. Pfizer 
11.7.12. Haselmeier
11.7.13. Other players.



SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650